Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

SaBP / Well Life Clinic ADHD Assessments & Treatment (10405)

Surrey and Borders Partnership NHS Foundation Trust · award, contract

Tender information last checkedLast checked 1 Oct 2026, 09:11.

Opportunity overview

Well Life Clinic ADHD Assessments for Adults<br/>This project relates to the procurement of adult ADHD assessment services to be delivered by Well Life Clinic. The service is required to support increasing demand for ADHD assessments within the adult population and to reduce waiting times, ensuring timely access to clinically appropriate diagnosis and onward care planning.<br/>The provider will be responsible for delivering comprehensive ADHD assessments in line with NICE guidance, including clinical evaluation, diagnosis, and recommendations for ongoing management where appropriate. The service will form part of the wider neurodevelopmental pathway and contribute to improved patient outcomes, earlier intervention, and reduced pressure on existing NHS services.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Published award value
Value not stated
Awarded
Not supplied
Contract signed
12 May 2026
Award ID
050136-2026-1
Status
active
Location
Surrey, UKJ2, RH8 0QE, United Kingdom

Classification

  • CPV85100000 — Health services

Lots

  • Well Life Clinic ADHD Assessments for Adults<br/>This project relates to the procurement of adult ADHD assessment services to be delivered by Well Life Clinic. The service is required to support increasing demand for ADHD assessments within the adult population and to reduce waiting times, ensuring timely access to clinically appropriate diagnosis and onward care planning.<br/>The provider will be responsible for delivering comprehensive ADHD assessments in line with NICE guidance, including clinical evaluation, diagnosis, and recommendations for ongoing management where appropriate. The service will form part of the wider neurodevelopmental pathway and contribute to improved patient outcomes, earlier intervention, and reduced pressure on existing NHS services.<br/><br/>Application of Key Selection Criteria – Direct Award A (PSR 2023, Regulation 23)<br/>This procurement is being undertaken using Direct Award A under Regulation 23 of the Provider Selection Regime (PSR) 2023. As such, the key selection criteria are not formally applied in this case.<br/>Direct Award A is not a comparative or competitive process. Instead, it is based on a threshold test, whereby the Authority must be satisfied that:<br/>• There is only one provider capable of delivering the required services, and<br/>• No reasonable alternative or substitute exists.<br/>The Authority has assessed the provision of ADHD assessment and treatment services and is satisfied that Well Life Clinic is the only provider currently able to deliver the required end-to-end service to the necessary standard, scale, and within the required timeframe.<br/>This position is supported by the following:<br/>• Demonstrated capability through pilot delivery: Well Life Clinic successfully delivered a pilot commissioned by the Authority, which achieved its intended objectives, including improved access, reduced waiting times, and high-quality clinical outcomes. The Authority was satisfied with the provider’s performance, confirming its capability and service model.<br/>• Absence of viable alternatives: Market assessment has not identified any alternative providers able to deliver a comparable ADHD pathway (assessment through to treatment and stabilisation) with sufficient capacity and within required mobilisation timelines.<br/>• Continuity of care and clinical risk: The service is already supporting patients within active assessment and treatment pathways. Introducing a new provider would present material risks to patient safety, continuity of care, and treatment outcomes, particularly for individuals undergoing diagnosis or medication titration.<br/>• Established integration and pathways: Well Life Clinic is embedded within existing referral routes and clinical pathways, including primary care interfaces, which would be complex and time-consuming to replicate elsewhere.<br/>Given the above, the Authority has determined that the conditions for Direct Award A are met, and therefore a formal evaluation against key selection criteria (e.g. quality, value, integration, inequalities) is not required.<br/>However, the Authority has taken assurance—through pilot evaluation, service performance, and market insight—that the proposed arrangement continues to deliver:<br/>• High-quality, safe, and effective care<br/>• Value for money<br/>• Improved access and patient outcomes<br/>This ensures that, while the criteria are not formally applied, the underlying principles of the PSR are still upheld in the decision-making process.Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-06a737
Status
complete
Main Procurement Category
services
Procurement Method
limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.'<br/><br/>Direct Award A is considered appropriate as Well Life Clinic is assessed to be the only provider capable of delivering the required service to the necessary standard within the required timeframe, informed by both market context and demonstrated performance, as outlined below:<br/>•Proven delivery through pilot programme: Well Life Clinic has previously delivered a pilot service commissioned by the Authority for ADHD assessment and treatment. The pilot demonstrated strong performance against key objectives, including improved access, reduced waiting times, and high-quality clinical outcomes. The Authority was satisfied with the delivery, responsiveness, and overall service model, providing assurance of the provider’s capability to deliver at scale.<br/><br/> Award decision-makers; Director of Learning Disabilities and Neurodiversity<br/> Deputy Chief Finance Officer - Strategic Finance<br/>Assistant Director of Contracts and Income<br/>Senior Contract Officer<br/>Senior Category Manager - Healthcare/Clinical Procurement<br/><br/><br/>No conflict of interest to report

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Scheme
CPV
Id
85100000
Description
Health services

Covered By

GPA

Procedure reasons

Entry 1
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Id
D_REPETITION_EXISTING
Description
New works/services, constituting a repetition of existing works/services and ordered in accordance with the strict conditions stated in the directive

Lots and requirements

Entry 1
Id
1
Description
Well Life Clinic ADHD Assessments for Adults<br/>This project relates to the procurement of adult ADHD assessment services to be delivered by Well Life Clinic. The service is required to support increasing demand for ADHD assessments within the adult population and to reduce waiting times, ensuring timely access to clinically appropriate diagnosis and onward care planning.<br/>The provider will be responsible for delivering comprehensive ADHD assessments in line with NICE guidance, including clinical evaluation, diagnosis, and recommendations for ongoing management where appropriate. The service will form part of the wider neurodevelopmental pathway and contribute to improved patient outcomes, earlier intervention, and reduced pressure on existing NHS services.<br/><br/>Application of Key Selection Criteria – Direct Award A (PSR 2023, Regulation 23)<br/>This procurement is being undertaken using Direct Award A under Regulation 23 of the Provider Selection Regime (PSR) 2023. As such, the key selection criteria are not formally applied in this case.<br/>Direct Award A is not a comparative or competitive process. Instead, it is based on a threshold test, whereby the Authority must be satisfied that:<br/>• There is only one provider capable of delivering the required services, and<br/>• No reasonable alternative or substitute exists.<br/>The Authority has assessed the provision of ADHD assessment and treatment services and is satisfied that Well Life Clinic is the only provider currently able to deliver the required end-to-end service to the necessary standard, scale, and within the required timeframe.<br/>This position is supported by the following:<br/>• Demonstrated capability through pilot delivery: Well Life Clinic successfully delivered a pilot commissioned by the Authority, which achieved its intended objectives, including improved access, reduced waiting times, and high-quality clinical outcomes. The Authority was satisfied with the provider’s performance, confirming its capability and service model.<br/>• Absence of viable alternatives: Market assessment has not identified any alternative providers able to deliver a comparable ADHD pathway (assessment through to treatment and stabilisation) with sufficient capacity and within required mobilisation timelines.<br/>• Continuity of care and clinical risk: The service is already supporting patients within active assessment and treatment pathways. Introducing a new provider would present material risks to patient safety, continuity of care, and treatment outcomes, particularly for individuals undergoing diagnosis or medication titration.<br/>• Established integration and pathways: Well Life Clinic is embedded within existing referral routes and clinical pathways, including primary care interfaces, which would be complex and time-consuming to replicate elsewhere.<br/>Given the above, the Authority has determined that the conditions for Direct Award A are met, and therefore a formal evaluation against key selection criteria (e.g. quality, value, integration, inequalities) is not required.<br/>However, the Authority has taken assurance—through pilot evaluation, service performance, and market insight—that the proposed arrangement continues to deliver:<br/>• High-quality, safe, and effective care<br/>• Value for money<br/>• Improved access and patient outcomes<br/>This ensures that, while the criteria are not formally applied, the underlying principles of the PSR are still upheld in the decision-making process.
Has Options
No
Status
cancelled

Award criteria

Criteria

Criterion 1
Type
price

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKJ2

Delivery Location

Description
Surrey and Borders Partnership NHS Foundation Trust<br/><br/>18 Mole Business Park, Randalls Road<br/><br/>Leatherhead<br/><br/>KT22 7AD

Buyer, suppliers and contacts

Organisation 1
Name
Surrey and Borders Partnership NHS Foundation Trust
Id
GB-FTS-125591

Identifier

Legal Name
Surrey and Borders Partnership NHS Foundation Trust

Address

Street Address
18 Mole Business Park, Randalls Road
Locality
Leatherhead
Region
UKJ2
Postal Code
KT22 7AD
Country Name
United Kingdom

Contact

Name
Taofeeq Ladega

Roles

buyer
reviewBody

Details

Classifications

Entry 1
Scheme
TED_CA_TYPE
Id
BODY_PUBLIC
Description
Body governed by public law
Entry 2
Scheme
COFOG
Id
07
Description
Health
Organisation 2
Name
Well Life Clinic Oxted Limited
Id
GB-FTS-182346

Identifier

Legal Name
Well Life Clinic Oxted Limited

Address

Street Address
125-131 Station Road East
Locality
Surrey
Region
UKJ2
Postal Code
RH8 0QE
Country Name
United Kingdom

Roles

supplier

Details

Scale
sme
Organisation 3
Name
Sussex Partnership NHS Foundation Trust
Id
GB-FTS-133310

Identifier

Legal Name
Sussex Partnership NHS Foundation Trust

Address

Street Address
Portland House, 44 Richmond Road
Locality
Worthing
Postal Code
BN11 1hs
Country Name
United Kingdom

Roles

reviewContactPoint

Details

Award information

Award 1
Id
050136-2026-1
Status
active

Related lots

1

Suppliers

Supplier 1
Id
GB-FTS-182346
Name
Well Life Clinic Oxted Limited

Contracts and changes

Entry 1
Id
050136-2026-1
Award ID
050136-2026-1
Status
active
Date Signed
13 May 2026, 00:00

Recorded locations

  • Buyer location · Leatherhead · UKJ2 · KT22 7AD · United Kingdom
  • Delivery location · UKJ2

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 050136-2026award, contract ·